Viridian Therapeutics Inc.

0K1R•London Stock Exchange

United Kingdom

Need professional-grade analysis? Visit stockanalysis.com

£14.45

-3.47%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	-2.75	-0.60	—	—	—	—	-1.31
Calmar	-17.97	-2.01	—	—	—	—	-7.33
Sharpe	-1.94	-0.59	—	—	—	—	-1.04
Omega	0.50	0.27	—	—	—	—	0.35
Martin	-29.15	-2.62	—	—	—	—	-11.46
Ulcer	1.99	38.19	—	—	—	—	26.12

Also Listed On

VRDN.US

United States · USD

$2.88B

Viridian Therapeutics Inc. (0K1R) Price Performance

Viridian Therapeutics Inc. (0K1R) trades on London Stock Exchange in GBP. The stock currently trades at GBP14.45, down 3.47% from the previous close.

Over the past year, 0K1R has traded between a low of GBP14.16 and a high of GBP33.40. The stock has lost 56.7% over this period. It is currently 56.7% below its 52-week high.

Company Info

Sector: N/A
Industry: N/A
Exchange: London Stock Exchange
Currency: GBP
Country: United Kingdom

Financial Metrics

Revenue (TTM): $70.85M
EBITDA: $-362,935,008
Profit Margin: N/A
EPS (TTM): -5.14
Book Value: 5.79

Technical Indicators

52 Week High: £34.19
52 Week Low: £13.36
50 Day MA: £25.37
200 Day MA: N/A
Beta: 1.17

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: 2.58
Enterprise Value: $829.13M